doxazosin has been researched along with Breast Cancer in 2 studies
Doxazosin: A prazosin-related compound that is a selective alpha-1-adrenergic blocker.
doxazosin : A member of the class of quinazolines that is quinazoline substituted by an amino group at position 4, methoxy groups at positions 6 and 7 and a piperazin-1-yl group at position 2 which in turn is substituted by a 2,3-dihydro-1,4-benzodioxin-2-ylcarbonyl group at position 4. An antihypertensive agent, it is used in the treatment of high blood pressure.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Krai, J | 1 |
| Beckenkamp, A | 1 |
| Gaelzer, MM | 1 |
| Pohlmann, AR | 1 |
| Guterres, SS | 1 |
| Filippi-Chiela, EC | 1 |
| Salbego, C | 1 |
| Buffon, A | 1 |
| Beck, RCR | 1 |
| Hui, H | 1 |
| Fernando, MA | 1 |
| Heaney, AP | 1 |
2 other studies available for doxazosin and Breast Cancer
| Article | Year |
|---|---|
Doxazosin nanoencapsulation improves its in vitro antiproliferative and anticlonogenic effects on breast cancer cells.
Topics: Breast Neoplasms; Cell Count; Cell Nucleus; Cell Proliferation; Cell Survival; Clone Cells; Doxazosi | 2017 |
The alpha1-adrenergic receptor antagonist doxazosin inhibits EGFR and NF-kappaB signalling to induce breast cancer cell apoptosis.
Topics: Adrenergic Antagonists; Antineoplastic Agents; Apoptosis; Blotting, Western; Breast Neoplasms; Cell | 2008 |